Hostname: page-component-7b7567c8c-jswmv Total loading time: 0 Render date: 2026-11-15T19:47:52.250Z Has data issue: false hasContentIssue false

Peer-provided Problem Management Plus (PM+) for adult Syrian refugees: a pilot randomised controlled trial on effectiveness and cost-effectiveness

Published online by Cambridge University Press:  18 August 2020

A. M. de Graaff*
Affiliation:
Department of Clinical, Neuro- and Developmental Psychology, Amsterdam Public Health Institute, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands
P. Cuijpers
Affiliation:
Department of Clinical, Neuro- and Developmental Psychology, Amsterdam Public Health Institute, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands
D. McDaid
Affiliation:
Department of Health Policy, Care Policy and Evaluation Centre, London School of Economics and Political Science, London, UK
A. Park
Affiliation:
Department of Health Policy, Care Policy and Evaluation Centre, London School of Economics and Political Science, London, UK
A. Woodward
Affiliation:
KIT Health, KIT Royal Tropical Institute, Amsterdam, The Netherlands
R. A. Bryant
Affiliation:
School of Psychology, University of New South Wales, Sydney, NSW, Australia
D. C. Fuhr
Affiliation:
Department of Health Services Research and Policy, Public Health and Policy, London School of Hygiene and Tropical Medicine, London, UK
B. Kieft
Affiliation:
i-Psy, Parnassia Groep, Almere, The Netherlands
E. Minkenberg
Affiliation:
i-Psy, Parnassia Groep, Den Haag, The Netherlands
M. Sijbrandij
Affiliation:
Department of Clinical, Neuro- and Developmental Psychology, Amsterdam Public Health Institute, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands
*
Author for correspondence: Anne M. de Graaff, E-mail: a.m.de.graaff@vu.nl
Rights & Permissions [Opens in a new window]

Abstract

Aims

Common mental disorders are highly prevalent among Syrian refugees. Problem Management Plus (PM+) is a brief, transdiagnostic, non-specialist helper delivered, psychological intervention targeting psychological distress. This single-blind pilot randomised controlled trial (RCT) on PM+ delivered by peer-refugees examined trial procedures in advance of a definitive RCT, evaluated PM+ 's acceptability and feasibility, and investigated its likely effectiveness and cost-effectiveness among Syrian refugees in the Netherlands.

Methods

Adult Syrian refugees (N = 60) with elevated psychological distress (Kessler Psychological Distress Scale (K10) score >15) and reduced pychosocial functioning (WHO Disability Assessment Schedule 2.0 (WHODAS) score >16) were randomised into PM+ in addition to care as usual (CAU) (PM+/CAU; n = 30) or CAU alone (n = 30). Primary outcomes were symptoms of depression and anxiety (Hopkins Symptom Checklist; HSCL-25) at 3-month follow-up. Secondary outcomes were pychosocial functioning (WHO Disability Assessment Schedule; WHODAS 2.0), symptoms of posttraumatic stress disorder (PTSD) (PTSD Checklist for DSM 5; PCL-5) and self-identified problems (Psychological Outcomes Profiles; PSYCHLOPS). Changes in service utilisation and time out of employment and/or adult education were estimated (adapted version of the Client Service Receipt Inventory; CSRI). Semi-structured interviews on the implementation of PM+ were conducted with stakeholders (i.e. six PM+ participants, five non-specialist helpers and five key informants).

Results

Recruitment, randomization and blinding procedures were successful. PM+ was generally perceived positively by stakeholders, especially regarding the intervention strategies, accommodation of the intervention and the helpers. Two serious adverse events not attributable to the trial were reported. At 3-month follow-up, the HSCL-25 total score was significantly lower for the PM+/CAU group (n = 30) than CAU group (n = 30) (p = 0.004; d = 0.58). Significant differences in favour of PM+/CAU were also found for WHODAS psychosocial functioning (p = 0.009, d = 0.73), PCL-5 symptoms of PTSD (p = 0.006, d = 0.66) and PSYCHLOPS self-identified problems (p = 0.005, d = 0.81). There were no significant differences in mean health service costs (p = 0.191) and the mean costs of lost productive time (p = 0.141). This suggests PM+ may potentially be cost-effective with an incremental cost from a health system perspective of €5047 (95% CI €0–€19 773) per additional recovery achieved.

Conclusions

Trial procedures and PM+ delivered by non-specialist peer-refugee helpers seemed acceptable, feasible and safe. Analyses indicate that PM+ may be effective in improving mental health outcomes and psychosocial functioning, and potentially cost-effective. These results support the development of a definitive RCT with a larger sample of refugees and a longer follow-up period.

Information

Type
Original Articles
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
Copyright © The Author(s), 2020. Published by Cambridge University Press
Figure 0

Fig. 1.CONSORT flow-diagram.

Figure 1

Table 1.Demographic characteristics

Figure 2

Table 2.Summary statistics and results from mixed-model analysis of primary and secondary outcomes

Figure 3

Fig. 2.HSCL-25 total score across time points.

Figure 4

Table 3.Mean health and productivity costs (2018 euros) per participant at 3-month follow-up

Figure 5

Table 4.Exploratory cost-effectiveness analyses (2018 euros)

Figure 6

Checklist A1.CONSORT 2010 Checklist of information to include when reporting a pilot or feasibility trial

Figure 7

Checklist A2.Consolidated Health Economic Evaluation Reporting Standards (CHEERS) Checklist

Figure 8

Checklist A3.Individual PM+ helper's component checklist

Figure 9

Appendix 2: Tables Table A1.Unit cost (2018 euros)

Figure 10

Table A2.Qualitative analysis themes and related quotes

Figure 11

Table A3.Missing data pattern

Figure 12

Table A4.Summary statistics and results from mixed-model analysis of primary and secondary outcomes without PM+ non-completers

Figure 13

Table A5.Reliable change index at post-assessment and 3-month follow-up for the HSCL-25 (completers only)

Figure 14

Fig. A1Cost-effectiveness plane: PM+/CAU v. CAU per recovery achieved (health system perspective).

Figure 15

Fig. A2Cost-effectiveness plane: PM+/CAU v. CAU per recovery achieved (health system and productivity perspective).

Figure 16

Fig. A3Cost-effectiveness plane: PM+/CAU v. CAU per improvement achieved (health system perspective).

Figure 17

Fig. A4Cost-effectiveness plane: PM+/CAU v. CAU per recovery achieved (health system and productivity loss perspective).

Figure 18

Fig. A5Cost-effectiveness acceptability curve: willingness to pay per improvement achieved from PM+/CAU intervention (health system perspective).

Figure 19

Fig. A6Cost-effectiveness acceptability curve: willingness to pay per improvement achieved from PM+/CAU intervention (health system perspective).

Figure 20

Fig. A7Cost-effectiveness acceptability curve: willingness to pay per recovery achieved from PM+/CAU intervention (health system perspective).

Figure 21

Fig. A8Cost-effectiveness acceptability curve: willingness to pay per recovery achieved from PM+/CAU intervention (health system and productivity perspective).